Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinical Laboratory Management(Electronic Edition) ›› 2020, Vol. 08 ›› Issue (03): 186-191. doi: 10.3877/cma.j.issn.2095-5820.2020.03.012

Special Issue:

• Experiences Communication • Previous Articles     Next Articles

Summary of laboratory prevention and control management experience in SARS-CoV-2 infection epidemic situation

Mingchao Zhu1,(), Ya Zhu2   

  1. 1. Department of Clinical Laboratory, The First People′s Hospital of Tianmen, Tianmen Hubei 431700, China
    2. Department of Neurology, The First People′s Hospital of Tianmen, Tianmen Hubei 431700, China
  • Received:2020-04-03 Online:2020-08-28 Published:2020-08-28
  • Contact: Mingchao Zhu
  • About author:
    Corresponding author: Zhu Mingchao, E-mail:

Abstract:

Pneumonia caused by the 2019 novel coronavirus (SARS-CoV-2) has broken out in China since the end of 2019. Although the epidemic situation in China has been effectively brought under control, the world is still in an outbreak phase, and China is now facing the threat of imported cases. Laboratory testing (mainly nucleic acid detection) is one of the important methods for screening, early diagnosis and efficacy evaluation of new cases of coronavirus infection. However, laboratory biosafety protection is an important line of defense for inspectors and inspectors. During the epidemic, the inspection department of our hospital implemented a series of protective measures to standardize the inspection and inspection and prevention and control processes to the greatest extent, reducing the medical staff in the inspection department risk of nosocomial infection effectively.

Key words: COVID-19, Laboratory biosafety, Nosocomial infection, Psychological counseling

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinical Laboratory Management(Electronic Edition), All Rights Reserved.
Tel: 020-81340564;020-37103504 Fax: 020-37103505 E-mail: clinlab@cma.org.cn
Powered by Beijing Magtech Co. Ltd